Genomic Vision (Germany) Probability of Future Stock Price Finishing Over 706.78
| G09 Stock | EUR 706.78 0.59 0.08% |
Genomic |
Genomic Vision Target Price Odds to finish over 706.78
The tendency of Genomic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 706.78 | 90 days | 706.78 | about 71.82 |
Based on a normal probability distribution, the odds of Genomic Vision to move above the current price in 90 days from now is about 71.82 (This Genomic Vision Socit probability density function shows the probability of Genomic Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Genomic Vision has a beta of 0.27. This usually indicates as returns on the market go up, Genomic Vision average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Genomic Vision Socit will be expected to be much smaller as well. Additionally Genomic Vision Socit has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Genomic Vision Price Density |
| Price |
Predictive Modules for Genomic Vision
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genomic Vision Socit. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Genomic Vision Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genomic Vision is not an exception. The market had few large corrections towards the Genomic Vision's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genomic Vision Socit, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genomic Vision within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.27 | |
σ | Overall volatility | 32.81 | |
Ir | Information ratio | -0.09 |
Genomic Vision Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genomic Vision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genomic Vision Socit can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the revenue of 1.41 M. Net Loss for the year was (5 M) with loss before overhead, payroll, taxes, and interest of (4.86 M). | |
| Genomic Vision Socit has accumulated about 2.94 M in cash with (4.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
Genomic Vision Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genomic Stock often depends not only on the future outlook of the current and potential Genomic Vision's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genomic Vision's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.5 M |
Genomic Vision Technical Analysis
Genomic Vision's future price can be derived by breaking down and analyzing its technical indicators over time. Genomic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genomic Vision Socit. In general, you should focus on analyzing Genomic Stock price patterns and their correlations with different microeconomic environments and drivers.
Genomic Vision Predictive Forecast Models
Genomic Vision's time-series forecasting models is one of many Genomic Vision's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genomic Vision's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Genomic Vision Socit
Checking the ongoing alerts about Genomic Vision for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Genomic Vision Socit help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company reported the revenue of 1.41 M. Net Loss for the year was (5 M) with loss before overhead, payroll, taxes, and interest of (4.86 M). | |
| Genomic Vision Socit has accumulated about 2.94 M in cash with (4.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
Other Information on Investing in Genomic Stock
Genomic Vision financial ratios help investors to determine whether Genomic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genomic with respect to the benefits of owning Genomic Vision security.